|
|
FAQ
> Glossary of Terms > C Series > Containment
|
| |
Pharmaceutical & Cleanroom Glossary of Terms
A Series , B
Series , C Series , D Series
, E Series , F
Series , G Series , H
Series , I Series , K
Series , L Series , M
Series , N Series , O
Series , P Series , Q
Series , R Series , S
Series , T Series , U
Series , V Series , W
Series , X
Series , Y Series , Z
Series
First 1 -
60 Words, Next
60-120 Words Concurrent
Process Validation, Condensate,
Condenser, Conductivity,
Configurable
Software, Configuration,
Conformation, Conjugated
Protein, Consent
Decree, Conserved
Sequence, Containment, Contaminant,
Contamination, Contig,
Contig Map, Continous
Fermentation, Contract
Manufacturer, Control
Area, Control Group,
Control Parameter,
Control Serum, Controlled
Area, Conventional
Drugs, Conventional
Flow Cleanroom, Converted
Data, Convexity,
Corn Steep Liquor,
Corrosive, Corrosive
Liquid, Cosmid, CP(
Cyclic Polarization), Critical,
Critical Area, Critical
Device, Critical
Instrument, Critical
Parameter, Critical
Point, Critical
Process Step, Critical
Steps, Critical
Surface, Critical
System, Cross
Contamination, Cross
Over, Cryogenic
Liquid, Cryptography,
Culture Medium,
Cut, Cystic
Fibrosis, Cytokine,
Cytolysis, Cytopathic,
Cytoplasm, Cytosine(C),
Cytostatic Agents,
Cytotoxic, Cytotoxicity
Learn About Deadly
Cancer Mesothelioma due to Asbestos Exposure, it can affect
any one in the world
-
Containment
The action of confining within a defined space a microbiological
agent or other entity that is being cultured, stored, manipulated,
transported, or destroyed in order to prevent or limit its
contact with people and/or the environment. Methods to achieve
containment include physical and biological barriers and inactivation
using physical or chemical means.
- 1. Primary Containment. Addresses the protection of personnel
and the immediate laboratory environment from exposure to
infectious agents. It involves the use of closed containers
or safety biological cabinets along with secure operating
procedures.
- 2. Secondary Containment. A system of containment that prevents
the escape of infectious agents into the environment external
to the laboratory. It involves the use of rooms with specially
designed air handling, the existence of airlocks and/or sterilizers
for the exit of materials and secure operating procedures.
In many cases it may add to the effectiveness of primary containment.
- 1. Appendix G - Physical Containment specifies physical
containment for standard laboratory experiments and defines
Biosafety Level 1 (BL1) through Biosafety Level 4 (BL4). (also
see: Biosafety Level, and Table II - Section II - Comparison
of Good Large Scale Practice (GLSP) and Biosafety Level (BL)
- Large Scale (LS) Practice)
- 2. Appendix I - Biological Containment specifies levels
of biological containment (host vector systems) for prokaryotes
and defines Host Vector 1 Systems (HV1) and Host Vector 2
Systems (HV2). (also see: Host Vector (HV) System)
- 3. Appendix K - Physical Containment for Large Scale Uses
of Organisms Containing Recombinant DNA Molecules specifies
physical containment guidelines for large scale (over 10 liters)
research or production involving viable organisms containing
recombinant DNA molecules, and defines GLSP (Good Large Scale
Practice) through Biosafety Level 3-LS (Large Scale). (also
see: Biosafety Level, and Table II - Section II - Comparison
of Good Large Scale Practice (GLSP) and Biosafety Level (BL)
- Large Scale (LS) Practice)
- 4. Appendix P - Physical and Biological Containment for
Recombinant DNA Research Involving Plants specifies physical
and biological containment conditions and practices suitable
to the greenhouse conduct of experiments involving recombinant
DNA-containing plants, plant-associated microorganisms, and
small animals, and defines Biosafety Level 1-Plants (BL1-P)
through Biosafety Level 4-Plants (BL4-P).
- 5. Appendix Q - Physical and Biological Containment for
Recombinant DNA Research Involving Animals specifies containment
and confinement practices for research involving whole animals,
both those in which the animal's genome has been altered by
stable introduction of recombinant DNA, and experiments involving
viable recombinant DNA-modified microorganisms tested on whole
animals, and defines Biosafety Level 1-Animals (BL1-N) through
Biosafety Level 4-Animals (BL4-N).
|
|
| |
|
|
|